For a generation, Europe’s tobacco strategy could point to a clear win: smoking rates fell, packets turned ugly with health warnings, and lighting up indoors became socially unthinkable across much of the continent. That story is now colliding with a newer one. Flavoured disposable vapes, nicotine pouches tucked under the lip, and heated-tobacco sticks have surged among teenagers faster than the law has been able to follow, and the gap is forcing a reckoning over rules written for an earlier era.
The pressure point is the Tobacco Products Directive, the framework that governs what may be sold, how it is packaged and what it may contain. A public consultation on revising it closes on 15 June, and the responses will help shape legislative proposals the Commission is expected to table by the end of the year. The exercise has become a magnet for lobbying from every side: public-health groups demanding flavour bans and plain packaging for the new products, and an industry arguing that vapes and pouches are harm-reduction tools that help adults quit cigarettes.
Health ministers have already shown their hand. A growing bloc of member states has pressed the Commission to act urgently against novel nicotine products, warning that the current directive simply does not capture devices that did not exist when it was last overhauled. Their frustration is partly about delay; the revision has slipped repeatedly, and each postponement leaves national governments to improvise their own patchwork of bans, taxes and age limits. That fragmentation is precisely what a single-market rulebook is supposed to prevent.
The substantive worry is generational. Evaluations underpinning the review highlight how quickly these products have taken root among the young, with bright colours, sweet flavours and cheap disposable formats that read less like a smoking-cessation aid than a starter kit. Nicotine pouches in particular occupy a regulatory grey zone in many countries, sold openly because they contain no tobacco leaf, even as they deliver doses that can rival a cigarette. The science on long-term harm is still maturing, but the precautionary case for treating anything marketed to teenagers as a serious risk is not a difficult one to make.
There is a genuine tension here that the debate too often flattens. If vapes really do help committed smokers switch away from combustion, a blanket crackdown could push some back toward the deadliest product of all. The credible middle path, restricting flavours and marketing that appeal to children while keeping plainer products available to adults trying to quit, is harder to legislate than to describe, and it depends on enforcement that customs and national agencies have struggled to deliver against a flood of cheap imports.
What happens after the consultation closes will test whether the bloc can regulate at the speed its own markets move. Tobacco control was one of public health’s clearest victories of the past two decades. Preserving that gain now means writing rules nimble enough to cover whatever the industry engineers next, rather than spending another five years legislating against the product that has already been replaced.




